Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125428
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:28
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20240930.htm   iXBRL 10-Q 2261702
2 EX-10.1 aura-ex10_1.htm EX-10.1 83403
3 EX-10.2 aura-ex10_2.htm EX-10.2 31474
4 EX-10.3 aura-ex10_3.htm EX-10.3 115076
5 EX-31.1 aura-ex31_1.htm EX-31.1 17461
6 EX-31.2 aura-ex31_2.htm EX-31.2 18378
7 EX-32.1 aura-ex32_1.htm EX-32.1 17762
  Complete submission text file 0000950170-24-125428.txt   8691287

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20240930.xsd EX-101.SCH 1210093
74 EXTRACTED XBRL INSTANCE DOCUMENT aura-20240930_htm.xml XML 1325571
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 241448383
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)